Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease

Recent developments in our understanding of events underlying neurodegeneration across the central and peripheral nervous systems have highlighted the critical role that synapses play in the initiation and progression of neuronal loss. With the development of increasingly accurate and versatile animal models of neurodegenerative disease it has become apparent that disruption of synaptic form and function occurs comparatively early, preceding the onset of degenerative changes in the neuronal cell body. Yet, despite our increasing awareness of the importance of synapses in neurodegeneration, the mechanisms governing the particular susceptibility of distal neuronal processes are only now becoming clear. In this review we bring together recent developments in our understanding of cellular and molecular mechanisms regulating synaptic vulnerability. We have placed a particular focus on three major areas of research that have gained significant interest over the last few years: (i) the contribution of synaptic mitochondria to neurodegeneration; (ii) the contribution of pathways that modulate synaptic function; and (iii) regulation of synaptic degeneration by local posttranslational modifications such as ubiquitination. We suggest that targeting these organelles and pathways may be a productive way to develop synaptoprotective strategies applicable to a range of neurodegenerative conditions.

[1]  A. Hannan,et al.  Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington’s disease , 2013, Neuroscience.

[2]  O. Khwaja,et al.  Case of Infantile Onset Spinocerebellar Ataxia Type 5 , 2013, Journal of child neurology.

[3]  G. Pigino,et al.  Axonal degeneration in Alzheimer's disease: When signaling abnormalities meet the axonal transport system , 2013, Experimental Neurology.

[4]  B. Fogel,et al.  A Family with Spinocerebellar Ataxia Type 5 Found to Have a Novel Missense Mutation within a SPTBN2 Spectrin Repeat , 2013, The Cerebellum.

[5]  R. Rodenburg,et al.  The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases , 2013, Neurobiology of Disease.

[6]  M. Iijima,et al.  Mitochondrial dynamics in neurodegeneration. , 2013, Trends in cell biology.

[7]  P. Calabresi,et al.  New synaptic and molecular targets for neuroprotection in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[8]  S. D. Santos,et al.  Regulation of synapse composition by protein acetylation: the role of acetylated cortactin , 2013, Journal of Cell Science.

[9]  B. van Zundert,et al.  Early pathogenesis in the adult‐onset neurodegenerative disease amyotrophic lateral sclerosis , 2012, Journal of cellular biochemistry.

[10]  P. Spano,et al.  From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease , 2012, Brain Research.

[11]  Mayur B. Patel,et al.  Pathophysiology of acute brain dysfunction: what's the cause of all this confusion? , 2012, Current opinion in critical care.

[12]  B. Hyman,et al.  The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. , 2012, The American journal of pathology.

[13]  L. Raymond,et al.  Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice , 2012, Neurobiology of Disease.

[14]  E. Reits,et al.  The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue? , 2012, Biochemistry research international.

[15]  Haibo Wang,et al.  Intranuclear localization of apoptosis-inducing factor and endonuclease G involves in peroxynitrite-induced apoptosis of spiral ganglion neurons , 2012, Neurological research.

[16]  A. Hubbard,et al.  Proteogenomics of synaptosomal mitochondrial oxidative stress. , 2012, Free radical biology & medicine.

[17]  K. Rosenblum,et al.  Consolidation and translation regulation , 2012, Learning & memory.

[18]  R. Swerdlow,et al.  Ubiquitin proteasome system in Parkinson's disease: A keeper or a witness? , 2012, Experimental Neurology.

[19]  Alun Williams,et al.  Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A2 and synapse damage , 2012, Prion.

[20]  C. Culmsee,et al.  AIF depletion provides neuroprotection through a preconditioning effect , 2012, Apoptosis.

[21]  A. Morton,et al.  Combining Comparative Proteomics and Molecular Genetics Uncovers Regulators of Synaptic and Axonal Stability and Degeneration In Vivo , 2012, PLoS genetics.

[22]  Mary A. Logan,et al.  dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway , 2012, Science.

[23]  Subhojit Roy,et al.  α-Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis , 2012, The Journal of Neuroscience.

[24]  Janna H. Neltner,et al.  Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology , 2012, The Journal of Neuroscience.

[25]  P. McLean,et al.  Molecular Chaperones and Co-Chaperones in Parkinson Disease , 2012, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[26]  V. Perry,et al.  The Role of Activity in Synaptic Degeneration in a Protein Misfolding Disease, Prion Disease , 2012, PloS one.

[27]  R. Mukherjee,et al.  Dysfunction of the Ubiquitin Ligase Ube3a May Be Associated with Synaptic Pathophysiology in a Mouse Model of Huntington Disease* , 2012, The Journal of Biological Chemistry.

[28]  G. Boccaccio,et al.  Synaptic activity regulated mRNA-silencing foci for the fine tuning of local protein synthesis at the synapse , 2012, Communicative & integrative biology.

[29]  K. Chung,et al.  Alpha‐synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s disease , 2012, Journal of neurochemistry.

[30]  P. McLean,et al.  Protein degradation pathways in Parkinson’s disease: curse or blessing , 2012, Acta Neuropathologica.

[31]  M. Rich,et al.  Survival Motor Neuron Protein in Motor Neurons Determines Synaptic Integrity in Spinal Muscular Atrophy , 2012, The Journal of Neuroscience.

[32]  J. Molgó,et al.  Early Presynaptic and Postsynaptic Calcium Signaling Abnormalities Mask Underlying Synaptic Depression in Presymptomatic Alzheimer's Disease Mice , 2012, The Journal of Neuroscience.

[33]  Michael L. Wallace,et al.  Maternal Loss of Ube3a Produces an Excitatory/Inhibitory Imbalance through Neuron Type-Specific Synaptic Defects , 2012, Neuron.

[34]  F. Court,et al.  Mitochondria as a central sensor for axonal degenerative stimuli , 2012, Trends in Neurosciences.

[35]  E. Dalfo,et al.  Neurochemistry and the non-motor aspects of PD , 2012, Neurobiology of Disease.

[36]  N. Chattipakorn,et al.  Synaptic and nonsynaptic mitochondria demonstrate a different degree of calcium-induced mitochondrial dysfunction. , 2012, Life sciences.

[37]  C. Ballard,et al.  Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture , 2012, Journal of Neural Transmission.

[38]  J. Mellor,et al.  Homeostatic Synaptic Scaling Is Regulated by Protein SUMOylation* , 2012, The Journal of Biological Chemistry.

[39]  T. Südhof,et al.  Synapses and Alzheimer's disease. , 2012, Cold Spring Harbor perspectives in biology.

[40]  Suk-Ho Lee,et al.  Impaired Short-Term Plasticity in Mossy Fiber Synapses Caused by Mitochondrial Dysfunction of Dentate Granule Cells Is the Earliest Synaptic Deficit in a Mouse Model of Alzheimer's Disease , 2012, The Journal of Neuroscience.

[41]  F. Lattanzio,et al.  Impairments of synaptic plasticity in aged animals and in animal models of Alzheimer's disease. , 2012, Rejuvenation research.

[42]  M. Krams,et al.  Impaired mitochondrial function in psychiatric disorders , 2012, Nature Reviews Neuroscience.

[43]  Y. Jan,et al.  Calcium-Activated Chloride Channels (CaCCs) Regulate Action Potential and Synaptic Response in Hippocampal Neurons , 2012, Neuron.

[44]  R. Luján,et al.  Motorneurons Require Cysteine String Protein-α to Maintain the Readily Releasable Vesicular Pool and Synaptic Vesicle Recycling , 2012, Neuron.

[45]  J. Geddes,et al.  WldS Prevents Axon Degeneration through Increased Mitochondrial Flux and Enhanced Mitochondrial Ca2+ Buffering , 2012, Current Biology.

[46]  D. Mann,et al.  Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration. , 2012, Journal of proteome research.

[47]  D. Turner,et al.  Cellular Links between Neuronal Activity and Energy Homeostasis , 2012, Front. Pharmacol..

[48]  A. Smit,et al.  Synaptic proteome changes in a DNA repair deficient ercc1 mouse model of accelerated aging. , 2012, Journal of proteome research.

[49]  C. Moon,et al.  Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain , 2012, Anatomy & cell biology.

[50]  L. Schwarz,et al.  Ubiquitin-dependent endocytosis, trafficking and turnover of neuronal membrane proteins , 2012, Molecular and Cellular Neuroscience.

[51]  J. Cooper,et al.  Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann–Pick type C1 mice , 2012, Neurobiology of Disease.

[52]  D. Goldstein,et al.  Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease , 2012, PloS one.

[53]  Kristen M Harris,et al.  Ultrastructure of synapses in the mammalian brain. , 2012, Cold Spring Harbor perspectives in biology.

[54]  H. Querfurth,et al.  Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders , 2012, Journal of neurochemistry.

[55]  P. Reddy,et al.  Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. , 2012, Biochimica et biophysica acta.

[56]  Bingren Hu,et al.  Protein degradation pathways after brain ischemia. , 2012, Current drug targets.

[57]  Qian Cai,et al.  Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration , 2012, Nature Reviews Neuroscience.

[58]  S. Züchner,et al.  Mutations in the Gene DNAJC5 Cause Autosomal Dominant Kufs Disease in a Proportion of Cases: Study of the Parry Family and 8 Other Families , 2012, PloS one.

[59]  L. Raymond,et al.  Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function , 2011, Neuroscience.

[60]  A. Mammen,et al.  A Novel Conserved Isoform of the Ubiquitin Ligase UFD2a/UBE4B Is Expressed Exclusively in Mature Striated Muscle Cells , 2011, PloS one.

[61]  Y. Mazurová,et al.  The neurodegenerative process in a neurotoxic rat model and in patients with Huntington's disease: histopathological parallels and differences. , 2011, Acta histochemica.

[62]  T. Gillingwater,et al.  Morphologic and Functional Correlates of Synaptic Pathology in the Cathepsin D Knockout Mouse Model of Congenital Neuronal Ceroid Lipofuscinosis , 2011, Journal of neuropathology and experimental neurology.

[63]  J. Rothstein,et al.  β-III Spectrin Is Critical for Development of Purkinje Cell Dendritic Tree and Spine Morphogenesis , 2011, The Journal of Neuroscience.

[64]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[65]  Harry T Orr,et al.  Aminopyridines Correct Early Dysfunction and Delay Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1 , 2011, The Journal of Neuroscience.

[66]  Cori Bargmann,et al.  Microtubule-based localization of a synaptic calcium-signaling complex is required for left-right neuronal asymmetry in C. elegans , 2011, Development.

[67]  J. Trojanowski,et al.  α-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies , 2011, The Journal of Neuroscience.

[68]  R. Youle,et al.  Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. , 2011, Antioxidants & redox signaling.

[69]  C. Akerman,et al.  Genetically encoded proton sensors reveal activity-dependent pH changes in neurons , 2011, Front. Mol. Neurosci..

[70]  Wolfdieter Springer,et al.  Regulation of PINK1-Parkin-mediated mitophagy , 2011, Autophagy.

[71]  S. Böhm,et al.  Cellular Functions of Ufd2 and Ufd3 in Proteasomal Protein Degradation Depend on Cdc48 Binding , 2011, Molecular and Cellular Biology.

[72]  D. Butterfield,et al.  Redox proteomics in aging rat brain: Involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process , 2010, Journal of neuroscience research.

[73]  A. Wright,et al.  Synaptic Protection in the Brain of WldS Mice Occurs Independently of Age but Is Sensitive to Gene-Dose , 2010, PloS one.

[74]  G. McKhann,et al.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model , 2010, Proceedings of the National Academy of Sciences.

[75]  D. Mahad,et al.  Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease. , 2010, The American journal of pathology.

[76]  E. Schuman,et al.  Protein homeostasis and synaptic plasticity , 2010, The EMBO journal.

[77]  George Perry,et al.  Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. , 2010, International journal of clinical and experimental pathology.

[78]  R. Luján,et al.  Cysteine String Protein-α Prevents Activity-Dependent Degeneration in GABAergic Synapses , 2010, The Journal of Neuroscience.

[79]  L. Ranum,et al.  Spectrin mutations that cause spinocerebellar ataxia type 5 impair axonal transport and induce neurodegeneration in Drosophila , 2010, The Journal of cell biology.

[80]  J. Lucas,et al.  Presynaptic dysfunction in Huntington's disease. , 2010, Biochemical Society transactions.

[81]  M. Dutia,et al.  Loss of β-III Spectrin Leads to Purkinje Cell Dysfunction Recapitulating the Behavior and Neuropathology of Spinocerebellar Ataxia Type 5 in Humans , 2010, The Journal of Neuroscience.

[82]  P. Calabresi,et al.  Synaptic dysfunction in Parkinson's disease. , 2010, Biochemical Society transactions.

[83]  R. Robledo,et al.  Targeted deletion of βIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes , 2010, Proceedings of the National Academy of Sciences.

[84]  Alan R. Mardinly,et al.  The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc , 2010, Cell.

[85]  M. Figueiredo-Pereira,et al.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications , 2010, Apoptosis.

[86]  C. Moussa,et al.  Parkin reverses intracellular β‐amyloid accumulation and its negative effects on proteasome function , 2010, Journal of neuroscience research.

[87]  V. Bennett,et al.  Membrane domains based on ankyrin and spectrin associated with cell-cell interactions. , 2009, Cold Spring Harbor perspectives in biology.

[88]  Shu-ji Li,et al.  Mitochondrial BNIP3 upregulation precedes endonuclease G translocation in hippocampal neuronal death following oxygen-glucose deprivation , 2009, BMC Neuroscience.

[89]  W. H. Jordan,et al.  Kainic Acid-induced F-344 Rat model of Mesial Temporal Lobe Epilepsy: Gene Expression and Canonical Pathways , 2009, Toxicologic pathology.

[90]  J. Cooper,et al.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease , 2009, Human molecular genetics.

[91]  Seungbok Lee,et al.  Drosophila Atlastin regulates the stability of muscle microtubules and is required for synapse development. , 2009, Developmental biology.

[92]  E. Meehan,et al.  Structure of full-length ubiquitin-conjugating enzyme E2-25K (huntingtin-interacting protein 2). , 2009, Acta crystallographica. Section F, Structural biology and crystallization communications.

[93]  M. Cookson,et al.  Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. , 2009, Biochemistry.

[94]  D. Attwell,et al.  Miro1 Is a Calcium Sensor for Glutamate Receptor-Dependent Localization of Mitochondria at Synapses , 2009, Neuron.

[95]  Zhengping Jia,et al.  A critical role of Rho-kinase ROCK2 in the regulation of spine and synaptic function , 2009, Neuropharmacology.

[96]  Xinnan Wang,et al.  The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility , 2009, Cell.

[97]  Zhigang He,et al.  NAD and axon degeneration: From the Wlds gene to neurochemistry , 2009, Cell adhesion & migration.

[98]  M. Ehlers,et al.  Pruning and loss of excitatory synapses by the parkin ubiquitin ligase , 2008, Proceedings of the National Academy of Sciences.

[99]  Xiongwei Zhu,et al.  Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins , 2008, Proceedings of the National Academy of Sciences.

[100]  Fay Wang,et al.  The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches. , 2008, Human molecular genetics.

[101]  K. Shen,et al.  The role of the ubiquitin proteasome system in synapse remodeling and neurodegenerative diseases , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[102]  V. Schreiber,et al.  The expanding field of poly(ADP-ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects' Review Series , 2008, EMBO reports.

[103]  Mandana Amiri,et al.  Mitochondrial biogenesis in the axons of vertebrate peripheral neurons , 2008, Developmental neurobiology.

[104]  D. Holtzman,et al.  Active and passive immunotherapy for neurodegenerative disorders. , 2008, Annual review of neuroscience.

[105]  Ivan Dikic,et al.  Atypical ubiquitin chains: new molecular signals , 2008, EMBO reports.

[106]  K. Talbot,et al.  Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. , 2008, Human molecular genetics.

[107]  A. Orr,et al.  Impaired ubiquitin–proteasome system activity in the synapses of Huntington's disease mice , 2008, The Journal of cell biology.

[108]  P. Maycotte,et al.  Role of Inhibitor of Apoptosis Proteins and Smac/DIABLO in Staurosporine-induced Cerebellar Granule Neurons Death , 2008, Neurochemical Research.

[109]  Xiaoxiang Zheng,et al.  Axon & dendrite degeneration: Its mechanisms and protective experimental paradigms , 2008, Neurochemistry International.

[110]  R. Baloh,et al.  Mitochondrial Dynamics and Peripheral Neuropathy , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[111]  Cuiling Li,et al.  Docking of Axonal Mitochondria by Syntaphilin Controls Their Mobility and Affects Short-Term Facilitation , 2008, Cell.

[112]  E. Hoffman,et al.  Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. , 2008, American journal of human genetics.

[113]  P. Saftig,et al.  Synaptic Changes in the Thalamocortical System of Cathepsin D-Deficient Mice: A Model of Human Congenital Neuronal Ceroid-Lipofuscinosis , 2008, Journal of neuropathology and experimental neurology.

[114]  Kevin A. Robertson,et al.  Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene*S , 2007, Molecular & Cellular Proteomics.

[115]  Jeff W Lichtman,et al.  Imaging axonal transport of mitochondria in vivo , 2007, Nature Methods.

[116]  J. Caviston,et al.  Huntingtin facilitates dynein/dynactin-mediated vesicle transport , 2007, Proceedings of the National Academy of Sciences.

[117]  Sergej L Mironov,et al.  ADP regulates movements of mitochondria in neurons. , 2007, Biophysical journal.

[118]  M. Ehlers,et al.  Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function , 2007, Pharmacological Reviews.

[119]  I. Reynolds,et al.  Mitochondrial trafficking and morphology in healthy and injured neurons , 2006, Progress in Neurobiology.

[120]  M. Gentile,et al.  Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments , 2006, Journal of neuroscience research.

[121]  Y. Jan,et al.  Identification of E2/E3 Ubiquitinating Enzymes and Caspase Activity Regulating Drosophila Sensory Neuron Dendrite Pruning , 2006, Neuron.

[122]  P. Verstreken,et al.  Mitochondria at the Synapse , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[123]  Thomas H. Gillingwater,et al.  Synaptic Vulnerability in Neurodegenerative Disease , 2006, Journal of neuropathology and experimental neurology.

[124]  D. Chan Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.

[125]  G. Arbuthnott,et al.  Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. , 2006, Brain : a journal of neurology.

[126]  J. Geddes,et al.  Synaptic Mitochondria Are More Susceptible to Ca2+Overload than Nonsynaptic Mitochondria* , 2006, Journal of Biological Chemistry.

[127]  Hai Rao,et al.  What’s Ub Chain Linkage Got to Do with It? , 2006, Science's STKE.

[128]  C. Lively,et al.  Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. , 2006, Molecular biology of the cell.

[129]  T. Südhof,et al.  CSPα-deficiency causes massive and rapid photoreceptor degeneration , 2006 .

[130]  K. Nakayama,et al.  Mammalian E4 Is Required for Cardiac Development and Maintenance of the Nervous System , 2005, Molecular and Cellular Biology.

[131]  Xinran Liu,et al.  Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice , 2005, Neurobiology of Disease.

[132]  Sudarshan C. Upadhya,et al.  Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies. , 2005, Current pharmaceutical design.

[133]  P. Verstreken,et al.  Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions , 2005, Neuron.

[134]  A. Singleton Altered α-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin , 2005, Trends in Neurosciences.

[135]  A. d’Azzo,et al.  E3 Ubiquitin Ligases as Regulators of Membrane Protein Trafficking and Degradation , 2005, Traffic.

[136]  Jian Feng,et al.  Parkin Stabilizes Microtubules through Strong Binding Mediated by Three Independent Domains* , 2005, Journal of Biological Chemistry.

[137]  J. M. Kaplan,et al.  LIN-23-Mediated Degradation of β-Catenin Regulates the Abundance of GLR-1 Glutamate Receptors in the Ventral Nerve Cord of C. elegans , 2005, Neuron.

[138]  B. Ghetti,et al.  Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[139]  S. Harrison,et al.  Structure of an auxilin-bound clathrin coat and its implications for the mechanism of uncoating , 2004, Nature.

[140]  D. Fushman,et al.  Polyubiquitin chains: polymeric protein signals. , 2004, Current opinion in chemical biology.

[141]  G. Hajnóczky,et al.  Control of mitochondrial motility and distribution by the calcium signal , 2004, The Journal of cell biology.

[142]  Yong-Keun Jung,et al.  Alzheimer's disease meets the ubiquitin-proteasome system. , 2004, Trends in molecular medicine.

[143]  Roger Kurlan,et al.  A focus on the synapse for neuroprotection in Alzheimer disease and other dementias , 2004, Neurology.

[144]  E. Seeberg,et al.  Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro , 2004, Molecular and Cellular Biology.

[145]  O. Isacson,et al.  Generalized brain and skin proteasome inhibition in Huntington's disease , 2004, Annals of neurology.

[146]  J. Kordower,et al.  Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements , 2004, Journal of neurocytology.

[147]  T. Südhof,et al.  The Synaptic Vesicle Protein CSPα Prevents Presynaptic Degeneration , 2004, Neuron.

[148]  H. Ishimoto,et al.  Molecular clearance of ataxin‐3 is regulated by a mammalian E4 , 2004, The EMBO journal.

[149]  J. Glass,et al.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man , 2004, Experimental Neurology.

[150]  S. Scheff,et al.  Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.

[151]  Patrik Brundin,et al.  Huntington's disease: a synaptopathy? , 2003, Trends in molecular medicine.

[152]  Zhigang He,et al.  Involvement of the Ubiquitin-Proteasome System in the Early Stages of Wallerian Degeneration , 2003, Neuron.

[153]  E. Barrett,et al.  Inhibition of mitochondrial Ca2+ uptake affects phasic release from motor terminals differently depending on external [Ca2+]. , 2003, Journal of neurophysiology.

[154]  K. Broadie,et al.  The Ubiquitin Proteasome System Acutely Regulates Presynaptic Protein Turnover and Synaptic Efficacy , 2003, Current Biology.

[155]  V. Perry,et al.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.

[156]  K. Nakayama,et al.  Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a. , 2003, Biochemical and biophysical research communications.

[157]  D. Tagle,et al.  PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. , 2002, Human molecular genetics.

[158]  I. Forsythe,et al.  Presynaptic Mitochondrial Calcium Sequestration Influences Transmission at Mammalian Central Synapses , 2002, The Journal of Neuroscience.

[159]  George J. Augustine,et al.  Uncoating of Clathrin-Coated Vesicles in Presynaptic Terminals Roles for Hsc70 and Auxilin , 2001, Neuron.

[160]  S. Laughlin,et al.  An Energy Budget for Signaling in the Grey Matter of the Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[161]  O. Steward,et al.  Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons , 2000, The Journal of comparative neurology.

[162]  V. Perry,et al.  A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[163]  Gary Lynch,et al.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.

[164]  K. Abe,et al.  The ethanol metabolite acetaldehyde inhibits the induction of long‐term potentiation in the rat dentate gyrus in vivo , 1999, British journal of pharmacology.

[165]  T. Wieloch,et al.  Differences in the Activation of the Mitochondrial Permeability Transition Among Brain Regions in the Rat Correlate with Selective Vulnerability , 1999, Journal of neurochemistry.

[166]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[167]  N. Hirokawa,et al.  Targeted Disruption of Mouse Conventional Kinesin Heavy Chain kif5B, Results in Abnormal Perinuclear Clustering of Mitochondria , 1998, Cell.

[168]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[169]  K. Nagao,et al.  Intracytoplasmic inclusion bodies of the substantia nigra in myotonic dystrophy Immunohistochemical observations , 1997, Journal of the Neurological Sciences.

[170]  E. Buchner,et al.  The DnaJ-like cysteine string protein and exocytotic neurotransmitter release , 1997, Trends in Neurosciences.

[171]  J W Griffin,et al.  Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[172]  W. Meier-Ruge,et al.  Morphological plasticity of synaptic mitochondria during aging , 1993, Brain Research.

[173]  P. Maycox,et al.  Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling , 1992, The Journal of cell biology.

[174]  N W Kowall,et al.  Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[175]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[176]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[177]  N. Kieffer,et al.  Expression of platelet glycoproteins by erythroid blasts in four cases of trisomy 21. , 1989, Leukemia.

[178]  R. Ernst,et al.  The economic costs of Alzheimer's disease. , 1987, American journal of public health.

[179]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[180]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.

[181]  J. Clark,et al.  SYNAPTIC AND NON‐SYNAPTIC MITOCHONDRIA FROM RAT BRAIN: ISOLATION AND CHARACTERIZATION , 1977, Journal of neurochemistry.

[182]  G. Goldstein,et al.  Molecular conservation of 74 amino acid sequence of ubiquitin between cattle and man , 1975, Nature.

[183]  R. Menzies,et al.  The turnover of mitochondria in a variety of tissues of young adult and aged rats. , 1971, The Journal of biological chemistry.

[184]  澤田 知世 Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria , 2013 .

[185]  L. Mei,et al.  Synaptic dysfunction in schizophrenia. , 2012, Advances in experimental medicine and biology.

[186]  E. Marcello,et al.  Synaptic dysfunction in Alzheimer's disease. , 2012, Advances in experimental medicine and biology.

[187]  Zhihua Liu,et al.  Drosophila FMRP regulates microtubule network formation and axonal transport of mitochondria. , 2011, Human molecular genetics.

[188]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[189]  R. Burgoyne,et al.  Chaperoning the SNAREs: a role in preventing neurodegeneration? , 2010, Nature Cell Biology.

[190]  H. Peng,et al.  The function of mitochondria in presynaptic development at the neuromuscular junction. , 2008, Molecular biology of the cell.

[191]  M. Zatz,et al.  Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. , 2007, American journal of human genetics.

[192]  T. Südhof,et al.  CSPalpha-deficiency causes massive and rapid photoreceptor degeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[193]  A. Singleton Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin. , 2005, Trends in neurosciences.

[194]  T. Südhof,et al.  The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. , 2004, Neuron.

[195]  R. Malenka,et al.  AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.

[196]  D. Marshak,et al.  Calcium-binding proteins and the molecular basis of calcium action. , 1982, International review of cytology.

[197]  Z. Żak,et al.  The ubiquitin system as a balance between monomers and polymers in polypeptide structure. , 1977, Folia biologica.

[198]  Stefano Puglisi-Allegra,et al.  Mechanisms Underlying the Impairment of Hippocampal Long-term Potentiation and Memory in Experimental Parkinson's Disease Materials and Methods Procedure for L-dopa Treatments Immunohistological Procedure Behavioural Procedure , 2022 .